Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cyclerion Therapeutics (CYCN) Notes Payables (2020 - 2021)

Historic Notes Payables for Cyclerion Therapeutics (CYCN) over the last 2 years, with Q3 2021 value amounting to $3.5 million.

  • Cyclerion Therapeutics' Notes Payables changed 0.0% to $3.5 million in Q3 2021 from the same period last year, while for Sep 2021 it was $3.5 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $3.5 million for FY2020, which is N/A changed from last year.
  • According to the latest figures from Q3 2021, Cyclerion Therapeutics' Notes Payables is $3.5 million, which was down 0.0% from $3.5 million recorded in Q2 2021.
  • Over the past 5 years, Cyclerion Therapeutics' Notes Payables peaked at $3.5 million during Q2 2020, and registered a low of $3.5 million during Q2 2020.